Showing 2331-2340 of 5128 results for "".
Scientifically Speaking: New Directions in Acne Management, Part 2
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-2/19950/From the optimal, safe use of isotretinoin to the proper role for systemic antibiotics and beyond, there are multiple areas of systemic acne care that deserve attention. In the second of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti,Make The Experience Unforgettable
https://practicaldermatology.com/topics/practice-management/make-the-experience-unforgettable/18583/When practices looking for ways to differentiate should focus on creating amazing experiences, says Robert Rullo. One important consideration is the person answering your phones, who needs to convey your expertise and your story.Ask an Expert: Managing Pruritus in the Elderly
https://practicaldermatology.com/topics/psoriasis/askanexpertpt3/19032/From NewDermMD: Host Adam Friedman, MD gets experts to share their wisdom. In this edition, Timothy Berger, MD discuss the treatment of itchy skin (pruritus) in elderly patients.Managing Moderate-to-Severe Psoriasis
https://practicaldermatology.com/topics/psoriasis/managing-moderate-to-severe-psoriasis/19184/Practical Dermatology May/June 2026: Page-Turner Format
https://practicaldermatology.com/issues/mayjune-2026/practical-dermatology-mayjune-2026-page-turner-format/57248/Novel PsO Drug Could Be 'Closest Perception of a Cure,' Dr. Strober Says at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/novel-pso-drug-could-be-closest-perception-of-a-cure-dr-strober-says-at-maui-derm/32922/A novel monoclonal antibody targeting IL-23 for the treatment of psoriasis offers an extended half-life that will be a key differentiator for patients, according to Bruce Strober, MD, PhD.Dr. Eichenfield Urges Caution for Steroid-Phobia at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/dr-eichenfield-urges-caution-for-steroid-phobia-at-maui-derm/32919/In addition to the various clinical skin conditions that pediatric patients present with, dermatologists now must understand how to deal with steroid-phobia, according to Lawrence Eichenfield, MD.What people want and why it matters
https://practicaldermatology.com/topics/general-topics/what-people-want-and-why-it-matters/19526/Our patients differ in both their skin biology and their use of skin care products on a daily basis. Discover how understanding the behaviors and practices of men and women can allow better and more effective product recommendations.Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Clinical Focus: Psoriasis: New Data on Comorbidities Associated with Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-data-on-comorbidities-associated-with-psoriasis/21979/With data mounting, it is essential that dermatologists monitor all patients who may be at risk for comorbidities and provide referrals when indicated.